JW중외제약2우B

001067KOSPI

63.0 / 100

Reference Date: 2026-10-23

Financial Score30.5 / 40

News Sentiment12.5 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Roughly flat over the past month, with no recent news.

Score Calculation Basis

Detailed Financial Score

PER

19.63Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.03Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

17.60Industry Average 8.007.0Point

2.2x industry avg (excellent)

Debt Ratio

7.24Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.9% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼1.6% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 18.4% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (42%)

Current 49,750Won52-week high 61,50052-week low 41,000

1-month return3.0Point

1m -0.9% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0